Contact Us | Volunteer | Donate

Our mission is to raise public awareness of Brain Cancer, raise money for the UCLA Neuro-Oncology Program, and spotlight the talent, strength and courage of brain cancer patients.
Next Event
Art of the Brain 10th Anniversary Gala
 
"The Art of Accentuating the Positive"
 
SAVE THE DATE
 
Saturday, October 3, 2009
 
Join us on October 3, 2009 to celebrate Art of the Brain's Tenth Anniversary.  We will show our solidarity with the courageous men and women facing brain cancer and pay tribute to the unforgettable individuals we have sadly lost.  We will celebrate their talent and zest for life with a festival of gourmet food and wine.  There will also be a fabulous raffle and special performances.
  

Corporate Partners

 2009 Corporate Sponsors

NETWORK SPONSORS
 
The Balch Family
Alex Demos Foundation
 
 
LIFE SPONSORS
 
Richard Dean Anderson
Genentech
 
 
LEGACY AND LAUGHTER SPONSORS
 
Jennifer and Robert Lopata
The Johnny Mercer Foundation
 
 
 
COURAGE SPONSORS
 
The Annenberg Foundation
Beryl Companies
City National Bank
Joan & Jerry Doren
Greenberg Traurig, LLP
Judi & Roy Kaufman
The Shirley & Burt Harris Family Foundation
 
 
GRATITUDE SPONSORS
 
Howard Bernstein and Bunny Wasser
Joyce & William Bromiley
Marlene & David Capell
Carsey Family Foundation
Dina & Clint Eastwood
Gang, Tyre, Ramer & Brown
Hale Thornhill Foundation
Ilene & Stanley Gold
Kory Apton & Phil Griffin
Doris P. Haims
Karen Morin
Mary Green & Peter Rooney
Mace Siegel
Jadi & Gy Waldron
Werner Family Foundation
Yusko Family Foundatioin
 
 
Art of the Brain wishes to thank all of our sponsors for their support!
 
Whats New: Art of the Brain
Judi Kaufman: Brain cancer survivor founds nonprofit Art of the Brain to help other patients
10/20/2008 8:00 AM PST [Los Angeles Times]
Local Entrepreneur Judi Kaufman Fights Back Against Brain Cancer
10/12/2008 8:00 AM PST [Beverly Hills Courier]
Cancer survivor brings art, courage to other patients
9/17/2008 8:00 AM PST [The Jewish Journal]
Art of the Brain 8th Annual Gala - An Inspirational Global Pursuit for the Cure
4/1/2008 8:00 AM PST [BreakthroughsMag]
Art of the Brain to hold its 8th Annual Gala, "An Inspirational Global Pursuit for a Cure"
7/31/2007 8:00 AM PST [BarbaraMeltzer&Associates]

Brain Cancer Research In The News
U.S. Bankcard Services, Inc. Contributes $5,000 Towards Brain Tumor Research (PRWeb via Yahoo! News)
Mon, 15 Mar 2010 07:01:00 GMT
Former Wallaby Husley back after brain tumor (AP via Yahoo! Philippines News)
Sun, 14 Mar 2010 07:07:00 GMT
American Brain Tumor Association Recognizes Philadelphia Family Foundation With Annual Award (redOrbit)
Fri, 12 Mar 2010 20:26:01 GMT
Vietnam releases leading dissident from prison (AP via Yahoo! News)
Tue, 16 Mar 2010 10:50:17 GMT
Discovery of MiR-451 molecule may serve as a biomarker for brain tumor (News-Medical-Net)
Mon, 15 Mar 2010 05:15:00 GMT

Recent Initiatives funded in part by Art of the Brain
Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model.
Cancer Res
PMID: 19934335 ; 69(23):9133-40

Bevacizumab for recurrent ependymoma.
Neurology
73(20):1677-80.PMID: 19917990

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.
J Clin Oncol.
(28):4733-40; PMID: 19720927

Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.
Cancer Res
PMID: 19690143 ; 69(17):6889-98

Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone.
J Neurooncology
PMID: 19655089

The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.
Proc Natl Acad Sci U S A
PMID: 19625624

Striking the balance between PTEN and PDK1: it all depends on the cell context.
Genes Dev
PMID: 19651981

Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.
Cancer Cell
PMID: 19573811 ; 16(1):44-54.

Targeted therapy for malignant glioma patients: lessons learned and the road ahead.
Neurotherapeutics
PMID:19561256 ; 252(1):182-9.

Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.
Radiology
252(1):182-9.PMID: 19561256

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
J Neurooncology
PMID: 19562255

The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
Proc Natl Acad Sci U S A.
106(23):9435-40 PMID: 19478061


All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.Portions Copyright (Search, Chart, Content Publishing Tools) 1998-2010 SiliconMED

© 2010 Artofthebrain.org
All Rights Reserved.

[Content Published:3/16/2010 7:23:51 AM PST]